Therefore, further research are needed especially in animal models to standardize the stages of cancer progression as well the sites of the samples taken in order to determine the complexity and interaction of ELAVL1 and miR-200c in regulating TUBB3 expression and contribution to chemotherapy resistance and patient outcomes in ovarian cancer. Here, TUBB3 is linked to ovarian carcinoma.